Suicidality in adolescents being treated with antidepressant medications and the black box label: Position paper of the Society for Adolescent Medicine

Journal of Adolescent Health

Volumn 36, Issue 1, 2005, Pages 92-93

  Lock, James ^a   Walker, Leslie R ^b   Rickert, Vaughn I ^c   Katzman, Debra K ^d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^c Mailman Sch Pub Hlth Columbia U ^*  (United States)

^d Hospital for Sick   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

CHILD BEHAVIOR; CONFERENCE PAPER; DEPRESSION; FOOD AND DRUG ADMINISTRATION; HUMAN; MAJOR DEPRESSION; MALADJUSTMENT; PRIORITY JOURNAL; PSYCHOTHERAPY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SIDE EFFECT; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; TREATMENT OUTCOME;

ADOLESCENT; ADOLESCENT BEHAVIOR; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; HUMANS; PRACTICE GUIDELINES; PRODUCT LABELING; RISK FACTORS; SOCIETIES, MEDICAL; SUICIDE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 12344281056     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2004.11.125     Document Type: Conference Paper

References (14)

1. D.A. Brent Antidepressants and pediatric depression-the risk of doing nothing N Engl J Med 351 2004 1598 1601
2. P.M. Lewinsohn, H. Hops, R.E. Roberts, J.R. Seeley, J.A. Andrews Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students J Abnorm Psychol 102 1993 133 144
3. M. Kovacs Presentation and course of major depressive disorder during childhood and later years of the life span J Am Acad Child Adolesc Psychiatry 35 1996 705 715
4. P.M. Lewinsohn, P. Rohde, J.R. Seeley, D.N. Klein, I.H. Gotlib Natural course of adolescent major depressive disorder in a community sample predictors of recurrence in young adults Am J Psychiatry 157 2000 1584 1591
5. National Institute of Mental Health Depression in children and adolescents a fact sheet for physicians 2004 www.nimh.nih.gov/publicat/ depchildresfact.cfm. Accessed March 8
6. D.A. Brent Assessment and treatment of the youthful suicidal patient Ann N Y Acad Sci 932 2001 106 128
7. J. March, S. Silva, S. Petrycki Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression Treatment for Adolescents with Depression Study (TADS) randomized controlled trial JAMA 292 2004 807 820
8. G.J. Emslie, A.J. Rush, W.A. Weinberg A double-blind, randomized placebo-controlled trial of fluoxetine in children and adolescents with depression Arch Gen Psychiatry 54 1997 1031 1037
9. G.J. Emslie, J.H. Heiligenstein, K.D. Wagner Fluoxetine treatment for prevention of relapse of depression in children and adolescents a double-blind, placebo-controlled study J Am Acad Child Adolesc Psychiatry 41 2002 1205 1215
10. FDA launches a multi-pronged strategy to strengthen safeguards for children treatment with antidepressants medications, U.S. Food and Drug Administration, FDA News, October 15, 2004. www.fda.gov/bbs/topics/news/2004/ NEW01124.html Accessed November 11, 2004.
11. T.B. Newman A black-box warning for antidepressants in children? N Engl J Med 351 2004 1595 1598
12. D.A. Brent, B. Birmaher Adolescent depression N Engl J Med 347 2000 667 671
13. A.J. Zametkin, M.R. Alter, T. Yemini Suicide in teenagers assessment, management, and prevention JAMA 286 2001 3120 3125
14. R.M. Sarles Joint meeting of the Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee. Academy of Child and Adolescent Psychiatry 2004 http://www.aacap.org/Announcements/AACAP_Comment.html. Accessed September 28